Can Intensive Insulin Therapy Improve Outcomes of COVID-19 Patients

NCT05441631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

436

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
Dysglycemia

Interventions

DRUG: Insulin
DRUG: Subcutaneous Insulin

Sponsor

Benha University